Latest Cancer: Kidney news
Belzutifan Improves Progression-Free Survival in Advanced Renal Cell Cancer
posted August 23rd
by modernClinician Editorial Team
by modernClinician Editorial Team
Improvement Seen in Survival With Adjuvant Pembrolizumab in Kidney Cancer
posted April 18th
by modernClinician Editorial Team
by modernClinician Editorial Team
Bilateral Wilms Tumors That Grow During Chemo Mostly Stromal-Predominant
posted April 17th
by modernClinician Editorial Team
by modernClinician Editorial Team
Survival Improved With Everolimus in High-Risk Clear Cell Renal Cancer
posted October 23rd
by modernClinician Editorial Team
by modernClinician Editorial Team
Editor's Recommendations
.jpg)
Most Specialty Oral Anticancer Meds for Blood Cancers Are Initially Rejected by Insurers 
Drug Interactions Reducing Contraceptive Effectiveness Common in Epilepsy 
Urine Cell-Free RNA Shows Promise as Biomarker for Bladder Cancer 
1 in 3 With Lupus Take Supplements, Medications With Potential for Interactions Related Articles
Pembrolizumab-Belzutifan Tied to Improved Disease-Free Survival in Renal Cell Carcinoma 
Comparable Progression Risk Seen With Ablation Versus Surgery for T1a Renal Cell Carcinoma 
Incidence Rates Increased From 2003 to 2017 for Six Cancer Types in 42 Countries 
Global Burden of Renal Cancer Expected to Double by 2050 Monthly Specialist Briefings
Stay Connected
